Association of DAP12 with activating CD94/NKG2C NK cell receptors

Immunity

Volumn 8, Issue 6, 1998, Pages 693-701

  Lanier, Lewis L ^a   Corliss, Brian ^a   Wu, Jun ^a   Phillips, Joseph H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; EFFECTOR CELL; IMMUNOREACTIVITY; KILLER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; T LYMPHOCYTE ACTIVATION; TARGET CELL;

EID: 0032100703     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80574-9     Document Type: Article

References (68)

1. Baker, E., D'Andrea, A., Phillips, J.H., Sutherland, G.R., and Lanier, L.L. (1995). Natural killer cell receptor for HLA-B allotypes, NKB1: map position 19q13.4. Chromosome Res. 3, 511.
2. Berg, S.F., Dissen, E., Westgaard, I.H., and Possum, S. (1998). Two genes in the rat homologous to human NKG2. Eur. J. Immunol. 28, 444-450.
3. Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., and Moretta, L. (1996). The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183, 645-650.
4. Bléry, M., Delon, J., Trautmann, A., Cambiaggi, A., Olcese, L., Biassoni, R., Moretta, L., Chavrier, P., Moretta, A., Daëron, M., and Vivier, E. (1997). Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J. Biol. Chem. 272, 8989-8996.
5. Bonifacino, J.S., Cosson, P., and Klausner, R.D. (1990). Colocalized transmembrane determinants for ER degradation and subunit assembly explain the intracellular fate of TCR chains. Cell 63, 503-513.
6. Bonifacino, J.S., Shah, C.P., and Klausner, R.D. (1991). Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum. EMBO J. 10, 2783-2793.
7. Borges, L., Hsu, M.-L., Fanger, N., Kubin, M., and Cosman, D. (1997). A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159, 5192-5196.
8. Borrego, F., Ulbrecht, M., Weiss, E.H., Coligan, J.E., and Brooks, A.G. (1998). Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813-818.
9. Braud, V., Jones, E.Y., and McMichael, A. (1997). The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27, 1164-1169.
10. Braud, V.M., Allan, D.S.J., O'Callaghan, C.A., Soderstrom, K., D'Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H., Lanier, L.L., and McMichael, A.J. (1998). HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 391, 795-798.
11. Brooks, A.G., Posch, P.E., Scorzelli, C.J., Borrego, F., and Coligan, J.E. (1997). NKG2A complexed with CD94 defines a novel inhibitory NK cell receptor. J. Exp. Med. 185, 795-800.
12. Brumbaugh, K.M., Perez-Villar, J.J., Dick, C.J., Schoon, R.A., Lopez-Botet, M., and Leibson, P.J. (1996). Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J. Immunol. 157, 2804-2812.
13. Burshtyn, D.N., Scharenberg, A.M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., and Long, E.O. (1996). Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4, 77-85.
14. Campbell, K.S., Dessing, M., Lopez-Botet, M., Cella, M., and Colonna, M. (1996). Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184, 93-100.
15. Campbell, K.S., Cella, M., Carretero, M., Lopez-Botet, M., and Colonna, M. (1998). Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur. J. Immunol. 28, 599-609.
16. Cantoni, C., Biassoni, R., Pende, D., Sivori, S., Accame, L., Pareti, L., Semenzato, G., Moretta, L., Moretta, A., and Bottino, C. (1998). The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur. J. Immunol. 28, 327-338.
17. Carretero, M., Cantoni, C., Bellon, T., Bottino, C., Biassoni, R., Rodriguez, A., Perez-Villar, J.J., Moretta, L., Moretta, A., and Lopez-Botet, M. (1997). The CD94 and NKG2-A C type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27, 563-575.
18. Chang, C., Rodriguez, A., Carretero, M., Lopez-Botet, M., Phillips, J.H., and Lanier, L.L. (1995). Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 25, 2433-2437.
19. Colonna, M., and Samaridis, J. (1995). Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human NK cells. Science 268, 405-408.
20. Cosson, P., Lankford, S.P., Bonifacino, J.S., and Klausner, R.D. (1991). Membrane protein association by potential intramembrane change pairs. Nature 351, 414-416.
21. D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Phillips, J.H., and Lanier, L.L. (1995). Molecular cloning of NKB1: a natural killer cell receptorfor HLA-B allotypes. J. Immunol. 155, 2306-2310.
22. Dietrich, J., Hou, X., Wegener, A.M., and Geisler, C. (1994). CD3γ contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J. 13, 2156-2166.
23. Dietrich, J., Neisig, A., Hou, X., Wegener, A.-M., Gajhede, M., and Geisler, C. (1996). Role of CD3g in T cell receptor assembly. J. Cell Biol. 132, 299-310.
24. Dietrich, J., Kastrup, J., Nielsen, B.L., Odum, N., and Geisler, C. (1997). Regulation and function of the CD3γ DxxxLL motif: a binding site for adaptor protein-1 and adaptor protein-2 in vitro. J. Cell. Biol. 138, 271-281.
25. Dissen, E., Ber, S.F., Westgaard, I.H., and Fossum, S. (1997). Molecular characterization of a gene in the rat homologous to human CD94. Eur. J. Immunol. 27, 2080-2086.
26. Dohring, C., and Colonna, M. (1996). Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur. J. Immunol. 26, 365-369.
27. Fan, Q.R., Garboczi, D.N., Winter, C.C., Wagtmann, N., Long, E.O., and Wiley, D.C. (1996). Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 93, 7178-7183.
28. Fry, A., Lanier, L.L., and Weiss, A. (1996). Phosphotyrosines in the KIR motif of NKB1 are required for negative signaling and for association with PTP1C. J. Exp. Med. 184, 295-300.
29. Geraghty, D.E., Pei, J., Lipsky, B., Hansen, J.A., Taillon-Miller, P., Bronson, S.K., and Chaplin, D.D. (1992). Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes. Proc. Natl. Acad. Sci. USA 89, 2669-2673.
30. Hayami, K., Fukuta, D., Nishikawa, Y., Yamashita, Y., Inui, M., Ohyama, Y., Hikida, M., Ohmori, H., and Takai, T. (1997). Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J. Biol. Chem. 272, 7320-7327.
31. Houchins, J.P., Yabe, T., McSherry, C., and Bach, F.H. (1991). DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173, 1017-1020.
32. Houchins, J.P., Lanier, L.L., Niemi, E., Phillips, J.H., and Ryan, J.C. (1997). Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158, 3603-3609.
33. Kubagawa, H., Burrows, P.D., and Cooper, M.D. (1997). A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 94, 5261-5266.
34. Lanier, L.L. (1998a). Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 92, 705-707.
35. Lanier, L.L. (1998b). NK cell receptors. Annu. Rev. Immunol. 16, 359-393.
36. Lanier, L.L., and Recktenwald, D.J. (1991). Multicolor immunofluorescence and flow cytometry. Methods: A Companion to Methods in Enzymology 2, 192-199.
37. Lanier, L.L., Yu, G., and Phillips, J.H. (1989). Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342, 803-805.
38. Lanier, L.L., Chang, C., and Phillips, J.H. (1994). Human NKR-P1A: a disulfide linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153, 2417-2428.
39. Lanier, L.L., Corliss, B.C., Wu, J., Leong, C., and Phillips, J.H. (1998). Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707.
40. Lazetic, S., Chang, C., Houchins, J.P., Lanier, L.L., and Phillips, J.H. (1996). Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157, 4741-4745.
41. Le Drean, E., Vely, F., Olcese, L., Cambiaggi, A., Guia, S., Krystal, G., Gervois, N., Moretta, A., Jotereau, F., and Vivier, E. (1998). Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatase. Eur. J. Immunol. 28, 264-276.
42. Lee, N., Goodlett, D.R., Ishitani, A., Marquardt, H., and Geraghty, D.E. (1998a). HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160, 4951-4960.
43. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M., and Geraghty, D.E. (1998b). HLA-E is a major ligand for the NK inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95, 5199-5204.
44. Letourneur, F., and Klausner, R.D. (1992). A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69, 1143-1157.
45. Litwin, V., Gumperz, J., Parham, P., Phillips, J.H., and Lanier, L.L. (1994). NKB1: an NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180, 537-543.
46. Lopez-Botet, M. (1995). CD94 cluster report: overview of the characterization of the Kp43 NK-cell-associated surface antigen. In Leucocyte Typing V, S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.F. Tedder and R.F. Todd, eds. (Oxford: Oxford University Press), pp. 1437-1439.
47. Morley, B.J., Chin, K.N., Newton, M.E., and Weiss, A. (1988). The lysine residue in the membrane-spanning domain of the β chain is necessary for cell surface expression of the T cell antigen receptor. J. Exp. Med. 168, 1971-1978.
48. Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., and Vivier, E. (1997). Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158, 5083-5086.
49. Olcese, L., Lang, P., Vely, F., Cambiaggi, A., Marguet, D., Blery, M., Hippen, K.L., Biassoni, R., Moretta, A., Moretta, L., Cambier, J.C., and Vivier, E. (1996). Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156, 4531-4534.
50. Onihsi, M., Kinoshita, S., Morikawa, Y., Shibuya, A., Phillips, J., Lanier, L.L., German, D.M., Nolan, G.P., Miyajima, A., and Kitamura, T. (1996). Applications of retrovirus-mediated expression cloning. Exp. Hematology 24, 324-329.
51. Perez-Villar, J.J., Carretero, M., Navarro, F., Melero, I., Rodriguez, A., Bottino, C., Moretta, A., and Lopez-Botet, M. (1996). Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J. Immunol. 157, 5367-5374.
52. Pérez-Villar, J.J., Melero, I., Rodríguez, A., Carretero, M., Aramburu, J., Sivori, S., Orengo, A.M., Moretta, A., and Lopez-Botet, M. (1995). Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 154, 5779-5788.
53. Phillips, J.H., Chang, C., Mattson, J., Gumperz, J.E., Parham, P., and Lanier, L.L. (1996). CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, -B, and -C allotypes. Immunity 5, 163-172.
54. Plougastel, B., and Trowsdale, J. (1997). Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes. Eur. J. Immunol. 27, 2835-2839.
55. Rajagopalan, S., and Long, E.O. (1997). The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide specificity. J. Exp. Med. 185, 1523-1528.
56. Renedo, M., Arce, I., Rodriguez, A., Carretero, M., Lanier, L.L., Lopez-Botet, M., and Fernandez-Ruiz, E. (1997). The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 46, 307-311.
57. Rojo, S., Wagtmann, N., and Long, E.O. (1997). Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains. Eur. J. Immunol. 27, 568-571.
58. Samaridis, J., and Colonna, M. (1997). Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27, 660-665.
59. Scott, P., and Trinchieri, G. (1995). The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 7, 34-40.
60. Smith, H.R.C., Karlhofer, F.M., and Yokoyama, W.M. (1994). Ly-49 multigene family expressed by IL-2-activated NK cells. J. Immunol. 153, 1068-1079.
61. Trinchieri, G. (1989). Biology of natural killer cells. Adv. Immunol. 47, 187-376.
62. Uhrberg, M., Valiante, N.M., Shum, B.P., Shilling, H.G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L.L., and Parham, P. (1997). Human diversity in killer cell inhibitory receptor (KIR) genes. Immunity 7, 753-763.
63. Ulbrecht, M., Honka, T., Person, S., Johnson, J.P., and Weiss, E.H. (1992). The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J. Immunol. 149, 2945-2953.
64. Valiante, N.M., Uhrberg, M., Shilling, H.G., Lienert-Weidenbach, K., Arnett, K.L., D'Andrea, A., Phillips, J.H., Lanier, L.L., and Parham, P. (1997). Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7, 739-751.
65. Vance, R.E., Tanamachi, D.M., Hanke, T., and Raulet, D.H. (1997). Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur. J. Immunol. 27, 3236-3241.
66. Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M.S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., and Long, E.O. (1995a). Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra-and intracellular domains. Immunity 2, 439-449.
67. Wagtmann, N., Rajagopalan, S., Winter, C.C., Peruzzi, M., and Long, E.O. (1995b). Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3, 801-809.
68. Yssel, H., De Vries, J.E., Koken, M., van Blitterswijk, W., and Spits, H. (1984). Serum-free medium for the generation and the propagation of functional human cytotoxicand helper T cell clones. J. Immunol. Methods 72, 219-227.